Skip to main content
. 2020 May 13;22(9):1524–1532. doi: 10.1038/s41436-020-0826-1

Table 4.

Cancer occurrence in JPS patients.

Index patients Nonindex patients
Totala Total with featureb Totala Total with featureb
n n (% of total) Median age (years)c (IQR) n n (% of total) Median age (years)c (IQR)
Cancer 126 19 (15.1%) 37.5 (14.0) 95 15 (15.8%) 45.0 (14.0)
SMAD4 71 13 (18.3%) 42.0 (16.3) 56 13 (23.2%) 43.0 (13.0)
BMPR1A 55 6 (10.9%) 34.0 (6.3) 39 2 (5.1%) 55.0 (10.0)
Colorectal cancer 126 11 (8.7%) 36.0 (7.5) 95 10 (11.6%) 49.0 (15.5)
SMAD4 71 6 (8.5%) 39.0 (13.0) 56 9 (16.1%) 46.5 (14.0)
BMPR1A 55 5 (9.1%) 35.0 (9.0) 39 2 (5.1%) 55.0 (10)
Gastric cancer 126 4 (3.2%) 44.0 (12.5) 95 3 (3.2%) 42.0 (12.8)
SMAD4 71 4 (5.6%) 44.0 (12.5) 56 3 (5.4%) 42.0 (12.8)
BMPR1A 55 0 39 0
Multiple cancers 126 4 (3.2%) 95 2 (2.1%)
SMAD4 71 3 (4.2%) 56 2 (3.6%)
BMPR1A 55 1 (1.8%) 39 0

IQR interquartile range, JPS juvenile polyposis syndrome.

aTotal number of patients.

bTotal number of index or nonindex patients who presented with the respective symptom.

cDue to missing age at diagnosis the calculation of the median age is often based on fewer than the total number of patients with the respective feature.